Construction of a Cuproptosis-Related lncRNA Prognostic Model for Bladder Urothelial Carcinoma and Screening of Potential Drugs

Figure 12

(a) Survival analysis of mutation frequency and mutation load of risk lncRNA. (b) Mutation frequency of high-risk lncRNA in high- and low-risk groups. (c) Survival analysis of TMB. (d) Survival analysis of high and low risk in TMB.

(a)

(b)

(c)

(d)